HK1214302A1 - Isolated oligonucleotide and use thereof - Google Patents

Isolated oligonucleotide and use thereof

Info

Publication number
HK1214302A1
HK1214302A1 HK16102277.2A HK16102277A HK1214302A1 HK 1214302 A1 HK1214302 A1 HK 1214302A1 HK 16102277 A HK16102277 A HK 16102277A HK 1214302 A1 HK1214302 A1 HK 1214302A1
Authority
HK
Hong Kong
Prior art keywords
isolated oligonucleotide
oligonucleotide
isolated
Prior art date
Application number
HK16102277.2A
Other languages
Chinese (zh)
Inventor
吳璐
許奇武
王磊
原輝
Original Assignee
Bgi Tech Solutions Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bgi Tech Solutions Co Ltd filed Critical Bgi Tech Solutions Co Ltd
Publication of HK1214302A1 publication Critical patent/HK1214302A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6816—Hybridisation assays characterised by the detection means
HK16102277.2A 2013-04-16 2016-02-26 Isolated oligonucleotide and use thereof HK1214302A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN201310132864 2013-04-16
PCT/CN2014/075403 WO2014169810A1 (en) 2013-04-16 2014-04-15 Isolated oligonucleotide and use thereof

Publications (1)

Publication Number Publication Date
HK1214302A1 true HK1214302A1 (en) 2016-07-22

Family

ID=51730802

Family Applications (1)

Application Number Title Priority Date Filing Date
HK16102277.2A HK1214302A1 (en) 2013-04-16 2016-02-26 Isolated oligonucleotide and use thereof

Country Status (3)

Country Link
CN (1) CN105008536A (en)
HK (1) HK1214302A1 (en)
WO (1) WO2014169810A1 (en)

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2510096B2 (en) * 2009-12-10 2018-02-07 Regents of the University of Minnesota Tal effector-mediated dna modification
CN103025344B (en) * 2010-05-17 2016-06-29 桑格摩生物科学股份有限公司 Novel DNA-associated proteins and application thereof
US20120204282A1 (en) * 2011-02-04 2012-08-09 Sangamo Biosciences, Inc. Methods and compositions for treating occular disorders
US20140115726A1 (en) * 2011-04-05 2014-04-24 Cellectis New tale-protein scaffolds and uses thereof
EP2702160B1 (en) * 2011-04-27 2020-05-27 Amyris, Inc. Methods for genomic modification
WO2012152912A1 (en) * 2011-05-12 2012-11-15 Newvectys Genetically modified pig as a cancer prone model
US9370551B2 (en) * 2011-07-27 2016-06-21 The Broad Institute, Inc. Compositions and methods of treating head and neck cancer
CN102787125B (en) * 2011-08-05 2013-12-04 北京大学 Method for building TALE (transcription activator-like effector) repeated sequences
CN102864158B (en) * 2012-09-29 2014-04-23 北京大学 High-efficiency synthesis method of TALE (transcription activator like effectors) repeated segments for genetic fixed-point modification

Also Published As

Publication number Publication date
CN105008536A (en) 2015-10-28
WO2014169810A1 (en) 2014-10-23

Similar Documents

Publication Publication Date Title
IL269693A (en) Oligonucleotide probes and uses thereof
IL246221B (en) Indazoles and use thereof
HK1223975A1 (en) Nanobubble-containing composition and use thereof
ZA201602510B (en) Strigolactone formulations and uses thereof
GB201317889D0 (en) Product and use
EP2968304A4 (en) 4-phenylpiperidines, their preparation and use
HK1203493A1 (en) Substituted azabicycles and use thereof
EP2968303A4 (en) Octahydrocyclopentapyrroles, their preparation and use
GB201317286D0 (en) Composition and Use
GB201305277D0 (en) Novel combination and use
PL3038654T3 (en) New use
GB201305825D0 (en) New use
HK1214333A1 (en) Bracket and use
IL244214B (en) Thienopiperidine derivative and use thereof
HK1217964A1 (en) Cushion-like shaped body and use thereof
IL240248A0 (en) Met-binding agents and uses thereof
IL243433B (en) Tib2 layres and use thereof
SG11201504142WA (en) Inhibitory oligonucleotide and use thereof
HK1203198A1 (en) Substituted phenylimidazopyrazoles and use thereof
GB201307989D0 (en) Novel combinations and use
GB201320992D0 (en) Complex and uses thereof
WO2014202624A9 (en) Rasamsonia gene and use thereof
ZA201601880B (en) Hetero-transglycosylase and uses thereof
GB201307049D0 (en) Catalysts and use thereof
HK1214302A1 (en) Isolated oligonucleotide and use thereof